Table 3.
Drug. | Method Used | Loading Conditions | Results | Ref. |
---|---|---|---|---|
ANTIBACTERIALS | ||||
Carbenicillin | Soaking Unmodified Sauflon 85 lenses |
500 or 100 mg/ml | In tear film after 2 h (122.5 μg/mL and 28.0 ± 9.4 μg/mL for 500 and 100 mg/mL loading, respectively) |
Jain 1983 [156] |
Gentamicin | 40 mg/mL gentamicin |
In tear film after 6 h (1.75 μg/mL) |
||
Chloramphenicol | 100 mg/mL chloramphenicol |
In tear film after 4 h (4.66 ± 1.25 μg/mL) |
||
Gentamicin | Soaking Unmodified commercial HEMA lenses |
5 mg/mL solution overnight | In tear film for up to three days of contact lens wear (1.6 μg/mL) | Busin 1988 [157] |
Gentamicin, Kanamycin, Ciprofloxacin, Ofloxacin |
Soaking Unmodified Etafilcon A lenses |
3 mg/mL solution for one hour |
Compared to the standard prophylactic regimen (nine drops over two hours before surgery), statistically significantly higher concentrations in aqueous humour when using loaded lenses. | Hehl 1999 [158] |
Lomefloxacin | Soaking Unmodified Etafilcon A lenses |
3 mg/mL solution for one-hour vibration |
Concentration observed compared to hourly eye-drop instillation: Cornea: (213.96 ± 60.87 μg/mL vs. 31.48 ± 13.12 μg/mL) Aqueous humour: (26.6 ± 4.81 μg/mL vs. 4.69 ± 2.18 μg/mL). |
Machetta 2014 [159] |
Ciprofloxacin Moxifloxacin |
Soaking Unmodified commercial hydrogel and silicone hydrogel lenses |
3 mg /mL ciprofloxacin (pH 4.0) or 1 mg/mL moxifloxacin solution for 24 h |
For hydrogel lenses, release max.: Ciprofloxacin (109 ± 5 μg/lens) Moxifloxacin (226 ± 2 μg/lens) For silicone hydrogels: Ciprofloxacin (63 ± 6 μg/lens) Moxifloxacin (36 ± 1 μg/lens). |
Karlgard 2003 [160] Hui 2008 [161] Bajgrowicz 2015 [162] |
Moxifloxacin Gatifloxacin |
Soaking Modified anionic pHEMA-based lenses |
5 mg/mL moxifloxacin or 3 mg/mL gatifloxacin commercial solutions with autoclaving |
In vitro: peak drug release at 1 h: Gatifloxacin (1187.4 μg/lens) Moxifloxacin (1310.7 μg/lens) In vivo: drug concentration in the cornea, aqueous humour and crystalline lens were consistently higher than three instillations of antibiotic eye drops over 45 min. |
Kakisu 2013 [74] |
Ciprofloxacin | Soaking Molecularly imprinted acrylic acid pHEMA TRIS–based lenses |
In vitro/in vivo: 3 mg/mL pH 4.0 ciprofloxacin-HCl solution for 24 h after autoclaving |
In vitro: release of ciprofloxacin for up to 14 days. In vivo: significant reduction in the number of bacteria with modified lenses compared to unmodified lenses or no treatment. |
Hui 2012 [163] Hui 2014 [96] |
Polymyxin B | Soaking Molecularly imprinted acrylic acid pHEMA–based materials |
4 mg/mL polymyxin B solution for three days | In vitro: sustained release of polymyxin B for more than two weeks. |
Malakooti 2015 [95] |
Levofloxacin | Up to 10 layers of levofloxacin-laden liposomes (Prepared in 100 mg/mL solutions) Liposome surface ethacrylat on hioxifilcon B face |
In vitro: drug release into 3 mL of 150 mmol/L NaCl solution monitored byfluorescence |
In vitro: layers of liposomes: two (8 ± 3 μg/mL) five (24 ± 1 μg/mL) ten (40 ± 10 μg/mL) Release up to 120 h. |
Danion 2007 [163] |
Ciprofloxacin | Drug-loaded PLGA film between two layers of pHEMA |
1:1 ratio of ciprofloxacin to PLGA, solvent casted, between two layers of pHEMA |
In vitro: more than four weeks of zero-order release kinetics (134 μg/day). |
Ciolino 2009 [112] |
ANTIVIRALS | ||||
Modified heparan sulfate binding peptide G2-C |
Soaking Unmodified commercial Ocufilcon D lenses |
10 mg/mL G2-C solution for five days at 37 °C |
In vitro: release observed over eight days. In vivo: treatment of mouse corneas, after three days significant reduction of viruses. |
Jaishankar 2016 [164] |
ANTIFUNGALS | ||||
Natamycin | Soaking Unmodified commercial hydrogel and silicone hydrogel lenses |
2.6 mg/mL solution prepared using DMSO for 24 h |
199.4 ± 29.9 μg/lens | Phan 2013 [165] |
Natamycin Fluconazole |
Unmodified commercial hydrogel and silicone hydrogel lenses |
1 mg/mL solutions of each drug |
Limited yeast growth over 48 h. | Phan 2016 [166] |
Econazole | PLGA film between two layers of pHEMA |
200 mg of econazole incorporated into 100 mg of PLGA and ethyl acetate, formed into three different surface area sizes | Effective econazole fungicidal concentrations for upward of 21 days. | Ciolino 2011 [113] |
Fluconazole | Soaking Vitamin E (various amounts) deposited on commercial silicone hydrogel lenses |
0.7 mg/mL fluconazole solution prepared using PBS | Addition of 17% Vitamin E Fluconazole release (60 mg in 10 h) Addition of 66% of Vitamin E Fluconazole release (60 mg in 227 h) |
Peng 2010 [153] |
DMSO: dimethyl sulfoxide, PBS: phosphate-buffered saline, pHEMA: poly-2-hydroxyl ethyl methacrylate, PLGA: poly(lactic-co-glycolic acid), TRIS: tris(trimethyl siloxy) silyl-propyl methacrylate.